ASH：Exicure在二期试验中反弹，多发性骨髓瘤血细胞动员率达90%

FierceBiotechAvalyn aims for $182M IPO to fund phase 3 trials of reformulated respiratory drugs

Thermo FisherThermo Fisher Scientific Q1 Earnings Call Highlights - Yahoo Finance

AgilentDoes Agilent (A) Settling Axion Dispute Clarify Its Push Into Cloud Lab Data Recurring Revenues? - simplywall.st

10x Genomics BlogWhy 10x Genomics (TXG) Shares Are Trading Lower Today - Yahoo Finance

10x Genomics BlogLiquidCell Dx 任命前 Foundation Medicine、10x Genomics 和 IDT 高管 Mirna Jarosz 为首席执行官；任命前 Foundation Medicine 首席医疗官 Vincent A. Miller 博士为高级战略顾问 - BioSpace

Thermo FisherThermo Fisher Scientific: Why A Slow Q1 Does Not Reflect The Growth Opportunities - Seeking Alpha

MOONS'阿尔忒弥斯计划将如何助美国打造月球基地

AgilentAgilent Technologies Inc (A) Shares Fall 5.0% -- What GF Score o - GuruFocus

Thermo FisherThermo Fisher Scientific Inc. stock falls Thursday, underperforms market - MarketWatch

FierceBiotech尽管存在数据隐忧，罗氏口服SERD仍有望成为公司史上最大产品：高管

FierceBiotechRegeneron ushers in new genetic medicine era with groundbreaking gene therapy approval

Thermo FisherThermo Fisher CEO says onshoring push will bring a ‘tailwind’ for the Waltham company - The Business Journals